WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Structure Therapeutics earnings were -$214.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest GPCR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$106.2M, up 39.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GPCR reported annual earnings of -$141.2M, with 15.2% growth.

GPCR earnings history

Current Revenue
$0.0
Current Earnings
-$214.8M
Current Profit Margin
0%

GPCR Return on Equity

Current Company
-16.9%
Current Industry
-12.1%
Current Market
28.7%
GPCR's Return on Equity (-16.9%)... subscribe to Premium to read more.
High Return on Equity Performance

GPCR Return on Assets

Current Company
-16.1%
Current Industry
-9.4%
GPCR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GPCR announces earnings.

GPCR Return on Capital Employed

Current Company
-15.75%
Current Industry
-5%
GPCR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GPCR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GPCR-$209.62M-$214.84MN/A-$3.03
ADPT-$30.92M-$63.85MN/A-$0.41
LEGN$11.24M-$91.69MN/A-$0.50
VKTX-$534.35M-$534.80MN/A-$4.67
DNLI-$495.46M-$511.45MN/A-$2.84
View Top Biotech Stocks

Structure Therapeutics Earnings Reports & History FAQ

What were Structure Therapeutics's earnings last quarter?

On GPCR's earnings call on Aug 5, 2026, Structure Therapeutics (NASDAQ: GPCR) reported Q2 2026 earnings per share (EPS) of -$1.47, up 36.11% year over year. Total GPCR earnings for the quarter were -$106.16 million. In the same quarter last year, Structure Therapeutics's earnings per share (EPS) was -$1.08.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.

Is Structure Therapeutics profitable or losing money?

As of the last Structure Therapeutics earnings report, Structure Therapeutics is currently losing money. Structure Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$214.84 million, a 20.05% increase year over year.

What was GPCR's earnings growth in the past year?

As of Structure Therapeutics's earnings date in Aug 5, 2026, Structure Therapeutics's earnings has grown year over year. GPCR earnings in the past year totalled -$214.84 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.